STERIS Plc (Ireland) (STE) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$206.49

From 52W high−23.68%

Volume1.51M

Market cap$19.99B

P/E (TTM)25.0x

P/S (TTM)3.3x

Div yield0.95%

Key dataSep 18, 2026

Open

$206.49

From 52W high

−23.68%

Volume

1.51M

Market cap

$19.99B

ValuationView details →

P/E (Fwd)

17.9x

EV/EBITDA

11.9x

P/E (TTM)

25.0x

RSI (14)

25.7

MomentumView details →

1D Return

−1.44%

YTD Return

−18.92%

SummaryUpdated Jun 1, 2026

STERIS plc (NYSE:STE) is an Irish-domiciled multinational corporation that provides infection prevention and procedural products and services to healthcare facilities, pharmaceutical manufacturers, and medical device companies worldwide. Founded in 1985 and publicly traded since 1992, the company has grown through strategic acquisitions and organic expansion to become a leading provider of sterilization, disinfection, and surgical equipment solutions. STERIS operates through four main business segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental, serving customers across hospitals, pharmaceutical companies, medical device manufacturers, and dental practices globally.

Ask drillr about STERIS Plc (Ireland) →

ValuationView details →

P/E (Fwd)

17.9x

P/E (TTM)

25.0x

EV/EBITDA

11.9x

EV/Sales

3.6x

P/S (TTM)

3.3x

P/B (TTM)

2.8x

ProfitabilityView details →

Gross Margin

44.43%

Net Margin

13.33%

EBITDA Margin

29.99%

ROE (TTM)

11.17%

ROA (TTM)

7.50%

Asset Turnover

0.56x

GrowthView details →

Revenue YoY

+8.37%

EPS YoY

+25.00%

FCF YoY

+1.85%

Revenue CAGR 3Y

+9.38%

EPS CAGR 3Y

+94.97%

EBITDA YoY

+28.62%

MomentumView details →

1D Return

−1.44%

YTD Return

−18.92%

1Y Return

−17.37%

RSI (14)

25.7

vs 50D SMA

−8.61%

vs 200D SMA

−10.86%

Capital & dividendView details →

Debt/Equity

0.28x

Current Ratio

1.91x

Quick Ratio

1.35x

Div Yield

0.95%

Div Rate

$1.95

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$2.59

EPS Surprise

4.02%

Beats (12Q)

6/12

Next Q EPS Est

$2.68

Avg Surprise (4Q)

2.02%

Rev Surprise

0.34%

Financials snapshotView financials →

Revenue (TTM)

6.04B

Net Income (TTM)

805.10M

Op. CF (TTM)

1.29B

Next earningsNov 4, 2026 →

Latest newsMore news →

STERIS announced a $600 million investment to build a new chemistry manufacturing, research and distribution complex in North Carolina.42d ago

STERIS plc announced its financial results for the fiscal 2027 first quarter ended June 30, 2026, reporting total revenue of $1.5 billion, a 7% increase from $1.4 billion in the prior-year quarter, with constant currency organic revenue growth of 6%.46d ago

Similar companies

Shanghai MicroPort MedBot (Group) Co., Ltd.02252.HK Zimmer Biomet Holdings, Inc.ZBH Koninklijke Philips N.V.PHG Penumbra, Inc.PEN DexCom, Inc.DXCM Smith & Nephew plcSNN Find similar companies →

Latest newsMore news →

STERIS announced a $600 million investment to build a new chemistry manufacturing, research and distribution complex in North Carolina.42d ago STERIS plc announced its financial results for the fiscal 2027 first quarter ended June 30, 2026, reporting total revenue of $1.5 billion, a 7% increase from $1.4 billion in the prior-year quarter, with constant currency organic revenue growth of 6%.46d ago STERIS announced a $600 million investment to build a Formulated Chemistries manufacturing and distribution Center of Excellence in North Carolina, supporting sterilization and disinfection for global healthcare and pharmaceutical industries.46d ago